Fludrocortisone Acetate Tablet
NDC Package 70954-252-30

The code 70954-252-30 identifies a specific commercial package of 500 tablet in 1 bottle of Fludrocortisone Acetate, a human prescription drug labeled by Novitium Pharma Llc. This tablet is formulated for oral use and contains fludrocortisone acetate as the active substance.

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Novitium Pharma Llc on June 02, 2022. The current certification is valid through December 31, 2026.

Fludrocortisone is a man-made form of a natural substance (glucocorticoid) made by the body. It is used along with other medications (e.g., hydrocortisone) to treat low glucocorticoid levels caused by disease of the adrenal gland (e.g., Addison's disease, adrenocortical insufficiency, salt-losing adrenogenital syndrome). Glucocorticoids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal. They are also needed to break down carbohydrates in your diet.

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70954025230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.